As of 2025-05-22, the Fair Value of Isofol Medical AB (publ) (ISOFOL.ST) is -3.06 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.20 SEK, the upside of Isofol Medical AB (publ) is -354.76%.
With the market price of 1.20 SEK and our fair value calculation, Isofol Medical AB (publ) (ISOFOL.ST) is not a good investment. Investing in ISOFOL.ST stocks now will result in a potential loss of 354.76%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -188.99 | -200.25 | -159.79 | -37.07 | -43.49 | -125.92 |
| YoY growth | -16.96% | -5.96% | 20.20% | 76.80% | -17.31% | 11.35% |
| Market Cap (mil) | 193.82 |
| P/E | |
| Forward P/E |
| EPS | -0.27 |
| Avg earnings growth rate | 11.35% |
| TTM earnings | -43.49 |